Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Geron and Genetic Therapy enter licensing agreement to develop cancer therapy

Jan. 9, 2002

Telik updates progress of TLK-286

Jan. 9, 2002

MMP-2 inhibitors identified at Shionogi as anticancer agents

Jan. 8, 2002

NB-1011 enters phase I/II trial in colon cancer

Jan. 8, 2002

Abgenix initiates phase II trial of ABX-EGF in prostate cancer

Jan. 8, 2002

CDK inhibitors useful as anticancer agents reported by LG Chem

Jan. 7, 2002

Shire and HydroMed realign histrelin agreement

Jan. 7, 2002

Kyowa Hakko and Lilly report new potent antitumor compounds

Jan. 4, 2002

New dosage form of Atrix's Leuprogel licensed in by Sanofi-Synthelabo

Jan. 4, 2002

Japanese researchers identify new steroid sulfatase inhibitors

Jan. 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...